Figure 3From: The effects of ProAlgaZyme novel algae infusion on metabolic syndrome and markers of cardiovascular healthThe effect of ProAlgaZyme vs. placebo on HDL-cholesterol (mg/dL). Values are mean change at 4, 8 and 10 weeks compared to baseline within 95% confidence limits (+/- 1.96*(standard error of the mean)).Back to article page